OMDA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.9 NOK | +1.07% |
|
+10.50% | +2.43% |
| Jun. 05 | Omda AS (OB:OMDA) commences an Equity Buyback Plan under the authorization approved on April 25, 2024. | CI |
| May. 28 | Software Group Omda Launches NOK30 Million Share Buyback | MT |
| Sales 2024 * | 451M 42.14M | Sales 2025 * | 488M 45.61M | Capitalization | 774M 72.29M |
|---|---|---|---|---|---|
| Net income 2024 * | 16M 1.49M | Net income 2025 * | 23M 2.15M | EV / Sales 2024 * | 2.52 x |
| Net Debt 2024 * | 362M 33.81M | Net Debt 2025 * | 310M 28.96M | EV / Sales 2025 * | 2.22 x |
| P/E ratio 2024 * |
48.7
x | P/E ratio 2025 * |
33.8
x | Employees | 291 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.7% |
More Fundamentals
* Assessed data
More news
Latest transcript on Omda
More press releases
| 1 day | +1.07% | ||
| 1 week | +10.50% | ||
| Current month | +10.50% | ||
| 1 month | +7.67% | ||
| 3 months | +32.98% | ||
| 6 months | -9.76% | ||
| Current year | +2.43% |
1 week
34.30
42.50
1 month
30.9042.50
Current year
22.1042.50
1 year
22.1049.50
3 years
22.1097.40
5 years
22.10111.00
10 years
22.10111.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sverre Flatby
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - | |
Leif Egil Buen
COO | Chief Operating Officer | - | 14-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | - | |
| Director/Board Member | 64 | - | |
| Director/Board Member | 61 | 21-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 37.9 | +1.07% | 14,149 |
| 24-06-06 | 37.5 | +0.54% | 30,488 |
| 24-06-05 | 37.3 | -1.84% | 13,987 |
| 24-06-04 | 38 | +5.56% | 43,450 |
| 24-06-03 | 36 | +4.96% | 10,766 |
Real-time Oslo Bors, June 07, 2024 at 10:45 am EDT
More quotes
Omda AS, formerly known as CSAM HEALTH GROUP AS, is a Norway-based provider of specialised software for healthcare sector. Its specialized software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. The Companyâs product portfolio includes solutions in public safety, connected healthcare, women and children's health, laboratory information management systems, medical imaging, medication management, and health analytics. Its headquartered in Oslo, Norway with local offices in Sweden, Denmark, Finland, UK, Lithuania, Spain, New Zealand, the United States and the Philippines. The Company delivers software and services to almost all hospitals in the Nordic region.
Calendar
2024-08-23
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
37.9
NOK
Average target price
49
NOK
Spread / Average Target
+29.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.43% | 72.32M | |
| -4.87% | 29.6B | |
| +31.35% | 8.65B | |
| +34.03% | 4.42B | |
| -28.91% | 2.69B | |
| -9.91% | 1.6B | |
| -21.02% | 1.36B | |
| -35.78% | 1.1B | |
| +3.28% | 924M | |
| -43.36% | 791M |
- Stock Market
- Equities
- CSAM Stock
